People · Operator
Named in public records as an officer, director or promoter · active 2009–2018 · Other Health Care, Other Technology, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EarLens Corp | — | Other Health Care | Series C | $287.1M | $55.5M | 2016 |
| Moximed, Inc | — | Other Health Care | Series C | $187.8M | $499.6M | 2009 |
| TWELVE, Inc. | — | Other Technology | Series B | $88.8M | $1.1B | 2010 |
| Miramar Labs Inc | — | Other Health Care | Series B | $87.2M | $95.9M | 2010 |
| Kona Medical, Inc. | — | Biotechnology | Series B | $61.6M | $396.9M | 2015 |
| Satiety Inc | — | Other Health Care | Series B | $34.3M | $559.9M | 2009 |
| Cabochon Aesthetics Inc | — | Other Health Care | Seed | $4.0M | $9.9M | 2010 |
Henry A. Plain, Jr. at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Henry A. Plain, Jr. on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Hanson S. Gifford III | 3 | 11 |
| HENRY A. PLAIN | 3 | 5 |
| Mark Deem | 3 | 5 |
| William Facteau | 2 | 5 |
| Christopher A. Shen | 2 | 3 |
| Nimesh A. Shah | 2 | 2 |
| Christopher Gleason | 1 | 35 |
| Ryan Drant | 1 | 24 |
| John Nehra | 1 | 11 |
| Joshua Makower | 1 | 10 |
| Brian Halak | 1 | 10 |
| Peter Cohn | 1 | 10 |
| Csaba Truckai | 1 | 7 |
| John Freund | 1 | 7 |
| Robert W. Croce | 1 | 7 |
| Rodney Perkins | 1 | 6 |
| Immanuel Thangaraj | 1 | 6 |
| Robert K. Anderson | 1 | 6 |
| Hank Plain | 1 | 5 |
| David W. Stassen | 1 | 5 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.